| Product Code: ETC13249665 | Publication Date: Apr 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 150 | No. of Figures: 55 | No. of Tables: 32 |
North America Drug Testing Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 North America Drug Testing Market Overview |
3.1 North America Regional Macro Economic Indicators |
3.2 North America Drug Testing Market Revenues & Volume, 2021 & 2031F |
3.3 North America Drug Testing Market - Industry Life Cycle |
3.4 North America Drug Testing Market - Porter's Five Forces |
3.5 North America Drug Testing Market Revenues & Volume Share, By Countries, 2021 & 2031F |
3.6 North America Drug Testing Market Revenues & Volume Share, By Component, 2021 & 2031F |
3.7 North America Drug Testing Market Revenues & Volume Share, By Sample Type, 2021 & 2031F |
3.8 North America Drug Testing Market Revenues & Volume Share, By Drug Type, 2021 & 2031F |
3.9 North America Drug Testing Market Revenues & Volume Share, By End Use, 2021 & 2031F |
4 North America Drug Testing Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 North America Drug Testing Market Trends |
6 North America Drug Testing Market, 2021 - 2031 |
6.1 North America Drug Testing Market, Revenues & Volume, By Component, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 North America Drug Testing Market, Revenues & Volume, By Consumables, 2021 - 2031 |
6.1.3 North America Drug Testing Market, Revenues & Volume, By Instruments, 2021 - 2031 |
6.1.4 North America Drug Testing Market, Revenues & Volume, By Rapid Testing Devices, 2021 - 2031 |
6.1.5 North America Drug Testing Market, Revenues & Volume, By Services, 2021 - 2031 |
6.2 North America Drug Testing Market, Revenues & Volume, By Sample Type, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 North America Drug Testing Market, Revenues & Volume, By Urine samples, 2021 - 2031 |
6.2.3 North America Drug Testing Market, Revenues & Volume, By Oral Fluid Samples, 2021 - 2031 |
6.2.4 North America Drug Testing Market, Revenues & Volume, By Hair Sample, 2021 - 2031 |
6.2.5 North America Drug Testing Market, Revenues & Volume, By Other Samples, 2021 - 2031 |
6.3 North America Drug Testing Market, Revenues & Volume, By Drug Type, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 North America Drug Testing Market, Revenues & Volume, By Alcohol, 2021 - 2031 |
6.3.3 North America Drug Testing Market, Revenues & Volume, By Cannabis/Marijuana, 2021 - 2031 |
6.3.4 North America Drug Testing Market, Revenues & Volume, By Cocaine, 2021 - 2031 |
6.3.5 North America Drug Testing Market, Revenues & Volume, By Opioids, 2021 - 2031 |
6.3.6 North America Drug Testing Market, Revenues & Volume, By Amphetamine & Methamphetamine, 2021 - 2031 |
6.3.7 North America Drug Testing Market, Revenues & Volume, By LSD, 2021 - 2031 |
6.3.8 North America Drug Testing Market, Revenues & Volume, By Other Drug Types, 2021 - 2031 |
6.4 North America Drug Testing Market, Revenues & Volume, By End Use, 2021 - 2031 |
6.4.2 North America Drug Testing Market, Revenues & Volume, By Hospitals, 2021 - 2031 |
6.4.3 North America Drug Testing Market, Revenues & Volume, By Clinics, 2021 - 2031 |
6.4.4 North America Drug Testing Market, Revenues & Volume, By Other End Uses, 2021 - 2031 |
7 North America Drug Testing Market, By Countries, 2021 - 2031 |
7.1 Overview & Analysis |
7.2 North America Drug Testing Market, Revenues & Volume, By Component, 2021 - 2031 |
7.2.1 United States (US) Drug Testing Market, Revenues & Volume, By Component, 2021 - 2031 |
7.2.2 Canada Drug Testing Market, Revenues & Volume, By Component, 2021 - 2031 |
7.2.3 Rest of North America Drug Testing Market, Revenues & Volume, By Component, 2021 - 2031 |
7.3 North America Drug Testing Market Revenues & Volume Share, By Sample Type, 2021 & 2031F |
7.3.1 United States (US) Drug Testing Market, Revenues & Volume, By Sample Type, 2021 - 2031 |
7.3.2 Canada Drug Testing Market, Revenues & Volume, By Sample Type, 2021 - 2031 |
7.3.3 Rest of North America Drug Testing Market, Revenues & Volume, By Sample Type, 2021 - 2031 |
7.4 North America Drug Testing Market, Revenues & Volume, By Drug Type, 2021 - 2031 |
7.4.1 United States (US) Drug Testing Market, Revenues & Volume, By Drug Type, 2021 - 2031 |
7.4.2 Canada Drug Testing Market, Revenues & Volume, By Drug Type, 2021 - 2031 |
7.4.3 Rest of North America Drug Testing Market, Revenues & Volume, By Drug Type, 2021 - 2031 |
7.5 North America Drug Testing Market, Revenues & Volume, By End Use, 2021 - 2031 |
7.5.1 United States (US) Drug Testing Market, Revenues & Volume, By End Use, 2021 - 2031 |
7.5.2 Canada Drug Testing Market, Revenues & Volume, By End Use, 2021 - 2031 |
7.5.3 Rest of North America Drug Testing Market, Revenues & Volume, By End Use, 2021 - 2031 |
8 North America Drug Testing Market Key Performance Indicators |
9 North America Drug Testing Market - Export/Import By Countries Assessment |
10 North America Drug Testing Market - Opportunity Assessment |
10.1 North America Drug Testing Market Opportunity Assessment, By Countries, 2021 & 2031F |
10.2 North America Drug Testing Market Opportunity Assessment, By Component, 2021 & 2031F |
10.3 North America Drug Testing Market Opportunity Assessment, By Sample Type, 2021 & 2031F |
10.4 North America Drug Testing Market Opportunity Assessment, By Drug Type, 2021 & 2031F |
10.5 North America Drug Testing Market Opportunity Assessment, By End Use, 2021 & 2031F |
11 North America Drug Testing Market - Competitive Landscape |
11.1 North America Drug Testing Market Revenue Share, By Companies, 2022 |
11.2 North America Drug Testing Market Competitive Benchmarking, By Operating and Technical Parameters |
12 Top 10 Company Profiles |
13 Recommendations |
14 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here